Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT02649582
Brief Title: Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients (ADDIT-GLIO)

First Submitted : January 23, 2015
First Submitted that Met QC Criteria : January 5, 2016
First Posted : January 7, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : December 6, 2019
Last Update Posted : December 11, 2019